Latest News & Updates
Breaking News
3 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Sanofi's Nuvaxovid Shows Lower Reactogenicity Than mRNA Rival in Phase 4 Trial
Sanofi's COMPARE Phase 4 trial shows Nuvaxovid has statistically significant lower reactogenicity than Moderna's mNEXSPIKE across all endpoints.
Pharma Now Editorial Team
Bispecific PD-1xVEGF Data in NSCLC Raises Scale-Up Questions for Merck
Merck shares early PD-1xVEGF bispecific data in NSCLC but withholds phase 3 plans, raising questions about GMP scale-up readiness.
Pharma Now Editorial Team
Oral Biologics Push Forces Rethink of Formulation and Manufacturing
Oral biologics and macrocycle drugs are driving new formulation and manufacturing demands that pharma plants must prepare for now.
Pharma Now Editorial Team
Nasal Epinephrine Approval Signals GMP Shifts for Delivery Reformulations
ARS Pharma's nasal epinephrine approval highlights GMP, process validation, and regulatory challenges facing manufacturers pursuing delivery reformulations.
Pharma Now Editorial Team